Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

National Diabetes Awareness Month --- November 2006

In 2005, an estimated 20.8 million persons in the United States (approximately 7% of the population) had diabetes; however, only 14.6 million of these persons had received a diagnosis for their disease (1). According to current projections, by 2050, approximately 48 million persons in the United States will have diabetes diagnosed, nearly 9 million more persons than previously estimated for 2050 (2). In 2002, approximately 54 million adults in the United States had prediabetes (i.e., blood glucose levels higher than normal but not high enough to be classified as diabetes) (1). Obesity is a major factor, although not the sole factor, in the increased rate of newly diagnosed cases of diabetes. Lifestyle changes such as moderate weight loss and exercise can prevent or delay onset of type 2 diabetes among adults at high risk (3). Information on how to prevent and control diabetes is available at http://www.ndep.nih.gov/diabetes/diabetes.htm and http://www.cdc.gov/diabetes/ndep/index.htm.

November is National Diabetes Awareness Month. Throughout the month, MMWR will publish reports on diabetes and its complications in specific populations. This week's issue describes the first nationally representative study to estimate the proportion of U.S. adults with diabetes who have correctable visual impairments.

References

  1. CDC. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta, GA: US Department of Health and Human Services, CDC; 2005. Available at http://www.cdc.gov/diabetes/pubs/factsheet05.htm.
  2. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: United States, 2005--2050. Diabetes Care 2006;29:2114--6.
  3. Diabetes Prevention Program Research Group. Diet and exercise dramatically delay type 2 diabetes. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393--403.



Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #